van Huizen, A. M. Et Al. 2022. International eDelphi Study to Reach Consensus on the Methotrexate Dosing Regimen in Patients With Psoriasis. JAMA DERMATOLOGY , vol.158, no.5 , 561-572.

van Huizen, A. M., Menting, S. P., Gyulai, R., Iversen, L., van der Kraaij, G. E., Middelkamp-Hup, M. A., ... Warren, R. B.(2022). International eDelphi Study to Reach Consensus on the Methotrexate Dosing Regimen in Patients With Psoriasis. JAMA DERMATOLOGY , vol.158, no.5, 561-572.

van Huizen, Astrid Et Al. "International eDelphi Study to Reach Consensus on the Methotrexate Dosing Regimen in Patients With Psoriasis," JAMA DERMATOLOGY , vol.158, no.5, 561-572, 2022

van Huizen, Astrid M. Et Al. "International eDelphi Study to Reach Consensus on the Methotrexate Dosing Regimen in Patients With Psoriasis." JAMA DERMATOLOGY , vol.158, no.5, pp.561-572, 2022

van Huizen, A. M. Et Al. (2022) . "International eDelphi Study to Reach Consensus on the Methotrexate Dosing Regimen in Patients With Psoriasis." JAMA DERMATOLOGY , vol.158, no.5, pp.561-572.

@article{article, author={Astrid M. van Huizen Et Al. }, title={International eDelphi Study to Reach Consensus on the Methotrexate Dosing Regimen in Patients With Psoriasis}, journal={JAMA DERMATOLOGY}, year=2022, pages={561-572} }